Heartflow Inc at JPMorgan Healthcare Conference Transcript
Hello, everyone. We're going to get started here. Hope you had a good lunch. I'm Robbie Marcus, the med tech analyst at JPMorgan.
Very happy to introduce CEO of Heartflow, John Farquhar. John will give a presentation followed by some Q&A. John?
Thank you, Robbie. I appreciate the time today. Great to be here. Good to see everybody. So I'll jump into this. I'll give everybody an overview of Heartflow, and then I think we got some time at the end for Q&A.
So just to set the stage here, and these are all themes that you'll hear as I go through the presentation, but we are a software company. We use AI in everything we do. We deploy that software and that AI to the treatment, diagnosis, and management of coronary artery disease.
The company was founded in 2010, just down the road here from Stanford University. We had our first FDA clearance in 2014, and I've been the CEO for about 4.5 years now, so great
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
Trustpilot
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
